Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12-01

AUTHORS

Cédric Bretonnière, Mathieu Jozwiak, Christophe Girault, Pascal Beuret, Jean-Louis Trouillet, Nadia Anguel, Jocelyne Caillon, Gilles Potel, Daniel Villers, David Boutoille, Christophe Guitton

ABSTRACT

IntroductionBacterial meningitis among critically ill adult patients remains associated with both high mortality and frequent, persistent disability. Vancomycin was added to treatment with a third-generation cephalosporin as recommended by French national guidelines. Because animal model studies had suggested interest in the use of rifampin for treatment of bacterial meningitis, and after the introduction of early corticosteroid therapy (in 2002), there was a trend toward increasing rifampin use for intensive care unit (ICU) patients. The aim of this article is to report on this practice.MethodsFive ICUs participated in the study. Baseline characteristics and treatment data were retrospectively collected from charts of patients admitted with a diagnosis of acute bacterial meningitis during a 5-year period (2004–2008). The ICU mortality was the main outcome measure; Glasgow Outcome Scale and 3-month mortality were also assessed.ResultsOne hundred fifty-seven patients were included. Streptococcus pneumoniae and Neisseria meningitidis were the most prevalent causative microorganisms. The ICU mortality rate was 15 %. High doses of a cephalosporin were the most prevalent initial antimicrobial treatment. The delay between admission and administration of the first antibiotic dose was correlated with ICU mortality. Rifampin was used with a cephalosporin for 32 patients (ranging from 8 % of the cohort for 2004 to 30 % in 2008). Administration of rifampin within the first 24 h of hospitalization could be associated with a lower ICU survival. Statistical association between such an early rifampin treatment and ICU mortality reached significance only for patients with pneumococcal meningitis (p=0.031) in univariate analysis, but not in the logistic model.ConclusionsWe report on the role of rifampin use for patients with community-acquired meningitis, and the results of this study suggest that this practice may be associated with lower mortality in the ICU. Nevertheless, the only independent predictors of ICU mortality were organ failure and pneumococcal infection. Further studies are required to confirm these results and to explain how rifampin use would reduce mortality. More... »

PAGES

303

Journal

TITLE

Critical Care

ISSUE

1

VOLUME

19

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13054-015-1021-7

DOI

http://dx.doi.org/10.1186/s13054-015-1021-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049908856

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26306393


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Community-Acquired Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glasgow Outcome Scale", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospital Mortality", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intensive Care Units", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Meningitis, Bacterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Meningitis, Meningococcal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Meningitis, Pneumococcal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neisseria meningitidis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rifampin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Nantes, UPRES EA 3826, 1 rue Gaston Veil, F-44035, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.4817.a", 
          "name": [
            "Service de R\u00e9animation M\u00e9dicale Polyvalente, CHU Nantes, P\u00f4le Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France", 
            "Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Nantes, UPRES EA 3826, 1 rue Gaston Veil, F-44035, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bretonni\u00e8re", 
        "givenName": "C\u00e9dric", 
        "id": "sg:person.0733520503.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733520503.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de R\u00e9animation M\u00e9dicale, AP-HP, H\u00f4pitaux universitaires Paris-Sud, H\u00f4pital de Bic\u00eatre, 78 rue du G\u00e9n\u00e9ral Leclerc, F-94270, Le Kremlin-Bic\u00eatre, France", 
          "id": "http://www.grid.ac/institutes/grid.413784.d", 
          "name": [
            "Service de R\u00e9animation M\u00e9dicale Polyvalente, CHU Nantes, P\u00f4le Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France", 
            "Service de R\u00e9animation M\u00e9dicale, AP-HP, H\u00f4pitaux universitaires Paris-Sud, H\u00f4pital de Bic\u00eatre, 78 rue du G\u00e9n\u00e9ral Leclerc, F-94270, Le Kremlin-Bic\u00eatre, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jozwiak", 
        "givenName": "Mathieu", 
        "id": "sg:person.01261530416.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261530416.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Groupe de Recherche sur le Handicap Ventilatoire (GRHV), UPRES EA 3830-Institut de Recherche et d\u2019Innovation Biom\u00e9dicale (IRIB), Facult\u00e9 de M\u00e9decine et de Pharmacie, Universit\u00e9 de Rouen, F-76031, Rouen, France", 
          "id": "http://www.grid.ac/institutes/grid.10400.35", 
          "name": [
            "Service de R\u00e9animation M\u00e9dicale Polyvalente, CHU-H\u00f4pitaux de Rouen, H\u00f4pital Charles Nicolle, 1 rue de Germont, F-76000, Rouen, France", 
            "Groupe de Recherche sur le Handicap Ventilatoire (GRHV), UPRES EA 3830-Institut de Recherche et d\u2019Innovation Biom\u00e9dicale (IRIB), Facult\u00e9 de M\u00e9decine et de Pharmacie, Universit\u00e9 de Rouen, F-76031, Rouen, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Girault", 
        "givenName": "Christophe", 
        "id": "sg:person.01337665616.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337665616.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "CH Roanne, Service de R\u00e9animation M\u00e9dico-chirurgicale, 28 rue de Charlieu, F-42300, Roanne, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "CH Roanne, Service de R\u00e9animation M\u00e9dico-chirurgicale, 28 rue de Charlieu, F-42300, Roanne, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beuret", 
        "givenName": "Pascal", 
        "id": "sg:person.01012240142.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012240142.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de R\u00e9animation M\u00e9dicale, AP-HP, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Institut de Cardiologie, 47-53 boulevard de l\u2019H\u00f4pital, F-75651, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411439.a", 
          "name": [
            "Service de R\u00e9animation M\u00e9dicale, AP-HP, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Institut de Cardiologie, 47-53 boulevard de l\u2019H\u00f4pital, F-75651, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Trouillet", 
        "givenName": "Jean-Louis", 
        "id": "sg:person.01251562312.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251562312.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de R\u00e9animation M\u00e9dicale, AP-HP, H\u00f4pitaux universitaires Paris-Sud, H\u00f4pital de Bic\u00eatre, 78 rue du G\u00e9n\u00e9ral Leclerc, F-94270, Le Kremlin-Bic\u00eatre, France", 
          "id": "http://www.grid.ac/institutes/grid.413784.d", 
          "name": [
            "Service de R\u00e9animation M\u00e9dicale, AP-HP, H\u00f4pitaux universitaires Paris-Sud, H\u00f4pital de Bic\u00eatre, 78 rue du G\u00e9n\u00e9ral Leclerc, F-94270, Le Kremlin-Bic\u00eatre, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anguel", 
        "givenName": "Nadia", 
        "id": "sg:person.01023110151.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023110151.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de Bact\u00e9riologie, CHU Nantes, P\u00f4le Hospitalo-universitaire 7, place A. Ricordeau, F-44093, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.277151.7", 
          "name": [
            "Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Nantes, UPRES EA 3826, 1 rue Gaston Veil, F-44035, Nantes, France", 
            "Service de Bact\u00e9riologie, CHU Nantes, P\u00f4le Hospitalo-universitaire 7, place A. Ricordeau, F-44093, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Caillon", 
        "givenName": "Jocelyne", 
        "id": "sg:person.01144077727.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144077727.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service d\u2019Accueil des Urgences, CHU Nantes, P\u00f4le Hospitalo-universitaire 3, \u2019place A. Ricordeau, F-44093, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.277151.7", 
          "name": [
            "Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Nantes, UPRES EA 3826, 1 rue Gaston Veil, F-44035, Nantes, France", 
            "Service d\u2019Accueil des Urgences, CHU Nantes, P\u00f4le Hospitalo-universitaire 3, \u2019place A. Ricordeau, F-44093, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Potel", 
        "givenName": "Gilles", 
        "id": "sg:person.01137234721.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137234721.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de R\u00e9animation M\u00e9dicale Polyvalente, CHU Nantes, P\u00f4le Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.277151.7", 
          "name": [
            "Service de R\u00e9animation M\u00e9dicale Polyvalente, CHU Nantes, P\u00f4le Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Villers", 
        "givenName": "Daniel", 
        "id": "sg:person.01237413435.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237413435.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service des Maladies Infectieuses, CHU Nantes, P\u00f4le Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.277151.7", 
          "name": [
            "Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Nantes, UPRES EA 3826, 1 rue Gaston Veil, F-44035, Nantes, France", 
            "Service des Maladies Infectieuses, CHU Nantes, P\u00f4le Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boutoille", 
        "givenName": "David", 
        "id": "sg:person.0717112363.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717112363.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de R\u00e9animation M\u00e9dicale Polyvalente, CHU Nantes, P\u00f4le Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.277151.7", 
          "name": [
            "Service de R\u00e9animation M\u00e9dicale Polyvalente, CHU Nantes, P\u00f4le Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guitton", 
        "givenName": "Christophe", 
        "id": "sg:person.01350000735.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350000735.17"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/cc3821", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053128548", 
          "https://doi.org/10.1186/cc3821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11908-010-0110-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049740147", 
          "https://doi.org/10.1007/s11908-010-0110-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-009-0782-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002132119", 
          "https://doi.org/10.1007/s10096-009-0782-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-003-1935-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011512008", 
          "https://doi.org/10.1007/s00134-003-1935-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc356", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043028618", 
          "https://doi.org/10.1186/cc356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-007-0381-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049891381", 
          "https://doi.org/10.1007/s10096-007-0381-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12-01", 
    "datePublishedReg": "2015-12-01", 
    "description": "IntroductionBacterial meningitis among critically ill adult patients remains associated with both high mortality and frequent, persistent disability. Vancomycin was added to treatment with a third-generation cephalosporin as recommended by French national guidelines. Because animal model studies had suggested interest in the use of rifampin for treatment of bacterial meningitis, and after the introduction of early corticosteroid therapy (in 2002), there was a trend toward increasing rifampin use for intensive care unit (ICU) patients. The aim of this article is to report on this practice.MethodsFive ICUs participated in the study. Baseline characteristics and treatment data were retrospectively collected from charts of patients admitted with a diagnosis of acute bacterial meningitis during a 5-year period (2004\u20132008). The ICU mortality was the main outcome measure; Glasgow Outcome Scale and 3-month mortality were also assessed.ResultsOne hundred fifty-seven patients were included. Streptococcus pneumoniae and Neisseria meningitidis were the most prevalent causative microorganisms. The ICU mortality rate was 15 %. High doses of a cephalosporin were the most prevalent initial antimicrobial treatment. The delay between admission and administration of the first antibiotic dose was correlated with ICU mortality. Rifampin was used with a cephalosporin for 32 patients (ranging from 8 % of the cohort for 2004 to 30 % in 2008). Administration of rifampin within the first 24 h of hospitalization could be associated with a lower ICU survival. Statistical association between such an early rifampin treatment and ICU mortality reached significance only for patients with pneumococcal meningitis (p=0.031) in univariate analysis, but not in the logistic model.ConclusionsWe report on the role of rifampin use for patients with community-acquired meningitis, and the results of this study suggest that this practice may be associated with lower mortality in the ICU. Nevertheless, the only independent predictors of ICU mortality were organ failure and pneumococcal infection. Further studies are required to confirm these results and to explain how rifampin use would reduce mortality.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13054-015-1021-7", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1117766", 
        "issn": [
          "1364-8535", 
          "1466-609X"
        ], 
        "name": "Critical Care", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "keywords": [
      "community-acquired meningitis", 
      "rifampin use", 
      "ICU mortality", 
      "bacterial meningitis", 
      "acute community-acquired meningitis", 
      "intensive care unit patients", 
      "early corticosteroid therapy", 
      "ICU mortality rate", 
      "initial antimicrobial treatment", 
      "first antibiotic dose", 
      "charts of patients", 
      "acute bacterial meningitis", 
      "ill adult patients", 
      "care unit patients", 
      "Glasgow Outcome Scale", 
      "only independent predictor", 
      "administration of rifampin", 
      "ResultsOne hundred fifty", 
      "intensive care unit", 
      "use of rifampin", 
      "main outcome measures", 
      "animal model studies", 
      "third-generation cephalosporins", 
      "French national guidelines", 
      "corticosteroid therapy", 
      "ICU survival", 
      "pneumococcal meningitis", 
      "adult patients", 
      "unit patients", 
      "baseline characteristics", 
      "pneumococcal infection", 
      "persistent disability", 
      "independent predictors", 
      "organ failure", 
      "care unit", 
      "Outcome Scale", 
      "causative microorganisms", 
      "univariate analysis", 
      "hundred fifty", 
      "outcome measures", 
      "meningitis", 
      "antibiotic dose", 
      "national guidelines", 
      "patients", 
      "mortality rate", 
      "rifampin treatment", 
      "lower mortality", 
      "treatment data", 
      "high doses", 
      "high mortality", 
      "Streptococcus pneumoniae", 
      "antimicrobial treatment", 
      "mortality", 
      "Neisseria meningitidis", 
      "rifampin", 
      "cephalosporins", 
      "Further studies", 
      "treatment", 
      "statistical association", 
      "administration", 
      "logistic model", 
      "hospitalization", 
      "ICU", 
      "ICUs", 
      "admission", 
      "therapy", 
      "infection", 
      "study", 
      "vancomycin", 
      "diagnosis", 
      "doses", 
      "dose", 
      "pneumoniae", 
      "meningitidis", 
      "survival", 
      "disability", 
      "predictors", 
      "association", 
      "ConclusionsWe", 
      "use", 
      "guidelines", 
      "failure", 
      "aim", 
      "fifties", 
      "practice", 
      "charts", 
      "period", 
      "significance", 
      "role", 
      "measures", 
      "rate", 
      "results", 
      "model studies", 
      "data", 
      "delay", 
      "units", 
      "scale", 
      "analysis", 
      "microorganisms", 
      "trends", 
      "characteristics", 
      "introduction", 
      "article", 
      "interest", 
      "model"
    ], 
    "name": "Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study", 
    "pagination": "303", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049908856"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13054-015-1021-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26306393"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13054-015-1021-7", 
      "https://app.dimensions.ai/details/publication/pub.1049908856"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_680.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13054-015-1021-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13054-015-1021-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13054-015-1021-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13054-015-1021-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13054-015-1021-7'


 

This table displays all metadata directly associated to this object as RDF triples.

353 TRIPLES      21 PREDICATES      152 URIs      138 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13054-015-1021-7 schema:about N11631b019b3043699e9f01e6ec1b1578
2 N14c1980ddc1f49caaf181f1a3f08cf21
3 N180a87159791474d8687dc361cb45a46
4 N29a666ad437c4686ba1d07b3e3005696
5 N35dfb915299c49ad952329a9c961d826
6 N3ef2a776cbbf4660bb47ee2cb5ae0b9e
7 N4018cc1e311142e8a2de98c105dfb71b
8 N557b3b49d2344a84997caddeec1f8f6c
9 N577f2f75140f4c898292173f75293ee6
10 N57eaa1f050ee4a8fb536b984c35efb53
11 N6164b9abd1b54e42b0b704d3152577e0
12 N64bec86e54294bc287407a6816210ac2
13 N6dfb41060f8a4aba92aedb6c822dd707
14 Na881776f2a684aa28ae3377faf33a70e
15 Nd2b3560fd85849ad9f13f613c591a426
16 Ne853b63aae9e49f38eb254ff1da4feb6
17 Nf97ee9137cff46469d26d03a2c8eca48
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author N4799b852d93b47ad90145ff95502201f
21 schema:citation sg:pub.10.1007/s00134-003-1935-4
22 sg:pub.10.1007/s10096-007-0381-6
23 sg:pub.10.1007/s10096-009-0782-9
24 sg:pub.10.1007/s11908-010-0110-7
25 sg:pub.10.1186/cc356
26 sg:pub.10.1186/cc3821
27 schema:datePublished 2015-12-01
28 schema:datePublishedReg 2015-12-01
29 schema:description IntroductionBacterial meningitis among critically ill adult patients remains associated with both high mortality and frequent, persistent disability. Vancomycin was added to treatment with a third-generation cephalosporin as recommended by French national guidelines. Because animal model studies had suggested interest in the use of rifampin for treatment of bacterial meningitis, and after the introduction of early corticosteroid therapy (in 2002), there was a trend toward increasing rifampin use for intensive care unit (ICU) patients. The aim of this article is to report on this practice.MethodsFive ICUs participated in the study. Baseline characteristics and treatment data were retrospectively collected from charts of patients admitted with a diagnosis of acute bacterial meningitis during a 5-year period (2004–2008). The ICU mortality was the main outcome measure; Glasgow Outcome Scale and 3-month mortality were also assessed.ResultsOne hundred fifty-seven patients were included. Streptococcus pneumoniae and Neisseria meningitidis were the most prevalent causative microorganisms. The ICU mortality rate was 15 %. High doses of a cephalosporin were the most prevalent initial antimicrobial treatment. The delay between admission and administration of the first antibiotic dose was correlated with ICU mortality. Rifampin was used with a cephalosporin for 32 patients (ranging from 8 % of the cohort for 2004 to 30 % in 2008). Administration of rifampin within the first 24 h of hospitalization could be associated with a lower ICU survival. Statistical association between such an early rifampin treatment and ICU mortality reached significance only for patients with pneumococcal meningitis (p=0.031) in univariate analysis, but not in the logistic model.ConclusionsWe report on the role of rifampin use for patients with community-acquired meningitis, and the results of this study suggest that this practice may be associated with lower mortality in the ICU. Nevertheless, the only independent predictors of ICU mortality were organ failure and pneumococcal infection. Further studies are required to confirm these results and to explain how rifampin use would reduce mortality.
30 schema:genre article
31 schema:isAccessibleForFree true
32 schema:isPartOf N2d7e4b0dfdbf4c61b366a422c750c167
33 N44cb7c15bfbe42b8b691cd0178c34490
34 sg:journal.1117766
35 schema:keywords ConclusionsWe
36 French national guidelines
37 Further studies
38 Glasgow Outcome Scale
39 ICU
40 ICU mortality
41 ICU mortality rate
42 ICU survival
43 ICUs
44 Neisseria meningitidis
45 Outcome Scale
46 ResultsOne hundred fifty
47 Streptococcus pneumoniae
48 acute bacterial meningitis
49 acute community-acquired meningitis
50 administration
51 administration of rifampin
52 admission
53 adult patients
54 aim
55 analysis
56 animal model studies
57 antibiotic dose
58 antimicrobial treatment
59 article
60 association
61 bacterial meningitis
62 baseline characteristics
63 care unit
64 care unit patients
65 causative microorganisms
66 cephalosporins
67 characteristics
68 charts
69 charts of patients
70 community-acquired meningitis
71 corticosteroid therapy
72 data
73 delay
74 diagnosis
75 disability
76 dose
77 doses
78 early corticosteroid therapy
79 failure
80 fifties
81 first antibiotic dose
82 guidelines
83 high doses
84 high mortality
85 hospitalization
86 hundred fifty
87 ill adult patients
88 independent predictors
89 infection
90 initial antimicrobial treatment
91 intensive care unit
92 intensive care unit patients
93 interest
94 introduction
95 logistic model
96 lower mortality
97 main outcome measures
98 measures
99 meningitidis
100 meningitis
101 microorganisms
102 model
103 model studies
104 mortality
105 mortality rate
106 national guidelines
107 only independent predictor
108 organ failure
109 outcome measures
110 patients
111 period
112 persistent disability
113 pneumococcal infection
114 pneumococcal meningitis
115 pneumoniae
116 practice
117 predictors
118 rate
119 results
120 rifampin
121 rifampin treatment
122 rifampin use
123 role
124 scale
125 significance
126 statistical association
127 study
128 survival
129 therapy
130 third-generation cephalosporins
131 treatment
132 treatment data
133 trends
134 unit patients
135 units
136 univariate analysis
137 use
138 use of rifampin
139 vancomycin
140 schema:name Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study
141 schema:pagination 303
142 schema:productId N16d6eb8009f74ad99a06068a2ea1e88b
143 N6c55d17cf6d14a708fc25da5ff87663e
144 N6fdbcb9244b142219ac46e09cbedf944
145 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049908856
146 https://doi.org/10.1186/s13054-015-1021-7
147 schema:sdDatePublished 2022-10-01T06:41
148 schema:sdLicense https://scigraph.springernature.com/explorer/license/
149 schema:sdPublisher N0fd50746a53a4f16a2ba243b2754e98e
150 schema:url https://doi.org/10.1186/s13054-015-1021-7
151 sgo:license sg:explorer/license/
152 sgo:sdDataset articles
153 rdf:type schema:ScholarlyArticle
154 N0fd50746a53a4f16a2ba243b2754e98e schema:name Springer Nature - SN SciGraph project
155 rdf:type schema:Organization
156 N11631b019b3043699e9f01e6ec1b1578 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Humans
158 rdf:type schema:DefinedTerm
159 N14c1980ddc1f49caaf181f1a3f08cf21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Middle Aged
161 rdf:type schema:DefinedTerm
162 N16d6eb8009f74ad99a06068a2ea1e88b schema:name pubmed_id
163 schema:value 26306393
164 rdf:type schema:PropertyValue
165 N180a87159791474d8687dc361cb45a46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Community-Acquired Infections
167 rdf:type schema:DefinedTerm
168 N29a666ad437c4686ba1d07b3e3005696 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Retrospective Studies
170 rdf:type schema:DefinedTerm
171 N2d7e4b0dfdbf4c61b366a422c750c167 schema:issueNumber 1
172 rdf:type schema:PublicationIssue
173 N30b657ed198a4440a0d35dbbee50e634 rdf:first sg:person.01251562312.75
174 rdf:rest N5ef3fd8fb4c94553be99b4aeb04fb5c1
175 N35dfb915299c49ad952329a9c961d826 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Treatment Outcome
177 rdf:type schema:DefinedTerm
178 N3ef2a776cbbf4660bb47ee2cb5ae0b9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Meningitis, Meningococcal
180 rdf:type schema:DefinedTerm
181 N4018cc1e311142e8a2de98c105dfb71b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Female
183 rdf:type schema:DefinedTerm
184 N44cb7c15bfbe42b8b691cd0178c34490 schema:volumeNumber 19
185 rdf:type schema:PublicationVolume
186 N4799b852d93b47ad90145ff95502201f rdf:first sg:person.0733520503.01
187 rdf:rest Nd6fbf5294707430c9495792c743a7ae8
188 N54b7339fd07b4728be9265406e2ade82 rdf:first sg:person.01137234721.33
189 rdf:rest Ndf20422036924bb68fa276eed4afa357
190 N557b3b49d2344a84997caddeec1f8f6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Meningitis, Bacterial
192 rdf:type schema:DefinedTerm
193 N577f2f75140f4c898292173f75293ee6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Anti-Bacterial Agents
195 rdf:type schema:DefinedTerm
196 N57eaa1f050ee4a8fb536b984c35efb53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name France
198 rdf:type schema:DefinedTerm
199 N5ef3fd8fb4c94553be99b4aeb04fb5c1 rdf:first sg:person.01023110151.70
200 rdf:rest Nabcee24f05e54acead6a845b7df93711
201 N6164b9abd1b54e42b0b704d3152577e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Rifampin
203 rdf:type schema:DefinedTerm
204 N64bec86e54294bc287407a6816210ac2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Meningitis, Pneumococcal
206 rdf:type schema:DefinedTerm
207 N6c55d17cf6d14a708fc25da5ff87663e schema:name dimensions_id
208 schema:value pub.1049908856
209 rdf:type schema:PropertyValue
210 N6dfb41060f8a4aba92aedb6c822dd707 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Neisseria meningitidis
212 rdf:type schema:DefinedTerm
213 N6fdbcb9244b142219ac46e09cbedf944 schema:name doi
214 schema:value 10.1186/s13054-015-1021-7
215 rdf:type schema:PropertyValue
216 Na881776f2a684aa28ae3377faf33a70e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Intensive Care Units
218 rdf:type schema:DefinedTerm
219 Nabcee24f05e54acead6a845b7df93711 rdf:first sg:person.01144077727.91
220 rdf:rest N54b7339fd07b4728be9265406e2ade82
221 Nca49777341a8457fb2168ed71d0916a8 rdf:first sg:person.01337665616.35
222 rdf:rest Nd6b86def270a4d43adc1647c66802843
223 Nccf0989c1f394769909d6713df05e056 rdf:first sg:person.0717112363.18
224 rdf:rest Nfe12c7a1426346f5b7ea594c2050fe13
225 Nd2b3560fd85849ad9f13f613c591a426 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Glasgow Outcome Scale
227 rdf:type schema:DefinedTerm
228 Nd6b86def270a4d43adc1647c66802843 rdf:first sg:person.01012240142.84
229 rdf:rest N30b657ed198a4440a0d35dbbee50e634
230 Nd6fbf5294707430c9495792c743a7ae8 rdf:first sg:person.01261530416.55
231 rdf:rest Nca49777341a8457fb2168ed71d0916a8
232 Ndf20422036924bb68fa276eed4afa357 rdf:first sg:person.01237413435.63
233 rdf:rest Nccf0989c1f394769909d6713df05e056
234 Ne853b63aae9e49f38eb254ff1da4feb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
235 schema:name Hospital Mortality
236 rdf:type schema:DefinedTerm
237 Nf97ee9137cff46469d26d03a2c8eca48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
238 schema:name Male
239 rdf:type schema:DefinedTerm
240 Nfe12c7a1426346f5b7ea594c2050fe13 rdf:first sg:person.01350000735.17
241 rdf:rest rdf:nil
242 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
243 schema:name Medical and Health Sciences
244 rdf:type schema:DefinedTerm
245 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
246 schema:name Clinical Sciences
247 rdf:type schema:DefinedTerm
248 sg:journal.1117766 schema:issn 1364-8535
249 1466-609X
250 schema:name Critical Care
251 schema:publisher Springer Nature
252 rdf:type schema:Periodical
253 sg:person.01012240142.84 schema:affiliation grid-institutes:None
254 schema:familyName Beuret
255 schema:givenName Pascal
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012240142.84
257 rdf:type schema:Person
258 sg:person.01023110151.70 schema:affiliation grid-institutes:grid.413784.d
259 schema:familyName Anguel
260 schema:givenName Nadia
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023110151.70
262 rdf:type schema:Person
263 sg:person.01137234721.33 schema:affiliation grid-institutes:grid.277151.7
264 schema:familyName Potel
265 schema:givenName Gilles
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137234721.33
267 rdf:type schema:Person
268 sg:person.01144077727.91 schema:affiliation grid-institutes:grid.277151.7
269 schema:familyName Caillon
270 schema:givenName Jocelyne
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144077727.91
272 rdf:type schema:Person
273 sg:person.01237413435.63 schema:affiliation grid-institutes:grid.277151.7
274 schema:familyName Villers
275 schema:givenName Daniel
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237413435.63
277 rdf:type schema:Person
278 sg:person.01251562312.75 schema:affiliation grid-institutes:grid.411439.a
279 schema:familyName Trouillet
280 schema:givenName Jean-Louis
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251562312.75
282 rdf:type schema:Person
283 sg:person.01261530416.55 schema:affiliation grid-institutes:grid.413784.d
284 schema:familyName Jozwiak
285 schema:givenName Mathieu
286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261530416.55
287 rdf:type schema:Person
288 sg:person.01337665616.35 schema:affiliation grid-institutes:grid.10400.35
289 schema:familyName Girault
290 schema:givenName Christophe
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337665616.35
292 rdf:type schema:Person
293 sg:person.01350000735.17 schema:affiliation grid-institutes:grid.277151.7
294 schema:familyName Guitton
295 schema:givenName Christophe
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350000735.17
297 rdf:type schema:Person
298 sg:person.0717112363.18 schema:affiliation grid-institutes:grid.277151.7
299 schema:familyName Boutoille
300 schema:givenName David
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717112363.18
302 rdf:type schema:Person
303 sg:person.0733520503.01 schema:affiliation grid-institutes:grid.4817.a
304 schema:familyName Bretonnière
305 schema:givenName Cédric
306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733520503.01
307 rdf:type schema:Person
308 sg:pub.10.1007/s00134-003-1935-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011512008
309 https://doi.org/10.1007/s00134-003-1935-4
310 rdf:type schema:CreativeWork
311 sg:pub.10.1007/s10096-007-0381-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049891381
312 https://doi.org/10.1007/s10096-007-0381-6
313 rdf:type schema:CreativeWork
314 sg:pub.10.1007/s10096-009-0782-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002132119
315 https://doi.org/10.1007/s10096-009-0782-9
316 rdf:type schema:CreativeWork
317 sg:pub.10.1007/s11908-010-0110-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049740147
318 https://doi.org/10.1007/s11908-010-0110-7
319 rdf:type schema:CreativeWork
320 sg:pub.10.1186/cc356 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043028618
321 https://doi.org/10.1186/cc356
322 rdf:type schema:CreativeWork
323 sg:pub.10.1186/cc3821 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053128548
324 https://doi.org/10.1186/cc3821
325 rdf:type schema:CreativeWork
326 grid-institutes:None schema:alternateName CH Roanne, Service de Réanimation Médico-chirurgicale, 28 rue de Charlieu, F-42300, Roanne, France
327 schema:name CH Roanne, Service de Réanimation Médico-chirurgicale, 28 rue de Charlieu, F-42300, Roanne, France
328 rdf:type schema:Organization
329 grid-institutes:grid.10400.35 schema:alternateName Groupe de Recherche sur le Handicap Ventilatoire (GRHV), UPRES EA 3830-Institut de Recherche et d’Innovation Biomédicale (IRIB), Faculté de Médecine et de Pharmacie, Université de Rouen, F-76031, Rouen, France
330 schema:name Groupe de Recherche sur le Handicap Ventilatoire (GRHV), UPRES EA 3830-Institut de Recherche et d’Innovation Biomédicale (IRIB), Faculté de Médecine et de Pharmacie, Université de Rouen, F-76031, Rouen, France
331 Service de Réanimation Médicale Polyvalente, CHU-Hôpitaux de Rouen, Hôpital Charles Nicolle, 1 rue de Germont, F-76000, Rouen, France
332 rdf:type schema:Organization
333 grid-institutes:grid.277151.7 schema:alternateName Service de Bactériologie, CHU Nantes, Pôle Hospitalo-universitaire 7, place A. Ricordeau, F-44093, Nantes, France
334 Service de Réanimation Médicale Polyvalente, CHU Nantes, Pôle Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France
335 Service des Maladies Infectieuses, CHU Nantes, Pôle Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France
336 Service d’Accueil des Urgences, CHU Nantes, Pôle Hospitalo-universitaire 3, ’place A. Ricordeau, F-44093, Nantes, France
337 schema:name Faculté de Médecine, Université de Nantes, UPRES EA 3826, 1 rue Gaston Veil, F-44035, Nantes, France
338 Service de Bactériologie, CHU Nantes, Pôle Hospitalo-universitaire 7, place A. Ricordeau, F-44093, Nantes, France
339 Service de Réanimation Médicale Polyvalente, CHU Nantes, Pôle Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France
340 Service des Maladies Infectieuses, CHU Nantes, Pôle Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France
341 Service d’Accueil des Urgences, CHU Nantes, Pôle Hospitalo-universitaire 3, ’place A. Ricordeau, F-44093, Nantes, France
342 rdf:type schema:Organization
343 grid-institutes:grid.411439.a schema:alternateName Service de Réanimation Médicale, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de Cardiologie, 47-53 boulevard de l’Hôpital, F-75651, Paris, France
344 schema:name Service de Réanimation Médicale, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de Cardiologie, 47-53 boulevard de l’Hôpital, F-75651, Paris, France
345 rdf:type schema:Organization
346 grid-institutes:grid.413784.d schema:alternateName Service de Réanimation Médicale, AP-HP, Hôpitaux universitaires Paris-Sud, Hôpital de Bicêtre, 78 rue du Général Leclerc, F-94270, Le Kremlin-Bicêtre, France
347 schema:name Service de Réanimation Médicale Polyvalente, CHU Nantes, Pôle Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France
348 Service de Réanimation Médicale, AP-HP, Hôpitaux universitaires Paris-Sud, Hôpital de Bicêtre, 78 rue du Général Leclerc, F-94270, Le Kremlin-Bicêtre, France
349 rdf:type schema:Organization
350 grid-institutes:grid.4817.a schema:alternateName Faculté de Médecine, Université de Nantes, UPRES EA 3826, 1 rue Gaston Veil, F-44035, Nantes, France
351 schema:name Faculté de Médecine, Université de Nantes, UPRES EA 3826, 1 rue Gaston Veil, F-44035, Nantes, France
352 Service de Réanimation Médicale Polyvalente, CHU Nantes, Pôle Hospitalo-universitaire 3, place A. Ricordeau, F-44093, Nantes, France
353 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...